ARL
TXG icon

Altar Rock LLC’s 10x Genomics TXG Stock Holding History

Altar Rock LLC’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$404K Sell
10,546
-10,041
-49% -$263K 0.59% 29
2026
Q1 		$437K Buy
20,587
+830
+4% +$16.6K 0.51% 29
2025
Q4 		$322K Buy
+19,757
New +$298K 0.39% 45

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Altar Rock LLC's TXG Position: Q2 2026 in Review

Altar Rock LLC reduced its 10x Genomics (TXG) stake by 49% in Q2 2026, selling an estimated $263K and leaving 10,546 shares worth $404K. The position accounts for 0.59% of the portfolio, ranked #29.

Altar Rock LLC first reported a position in TXG in Q4 2025 and has held it in 3 quarters since. The position peaked at $437K in Q1 2026. 393 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Altar Rock LLC held 10,546 shares of 10x Genomics worth $404K as of Q2 2026.
  • Altar Rock LLC sold 10,041 10x Genomics shares in Q2 2026, an estimated $263K.
  • 10x Genomics made up 0.59% of Altar Rock LLC's portfolio in Q2 2026, its #29 holding.
  • Altar Rock LLC first reported a position in 10x Genomics in Q4 2025 and has held it in 3 quarters since.
  • Altar Rock LLC's 10x Genomics position peaked at $437K in Q1 2026.
  • 393 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Altar Rock LLC's 13F filing for Q2 2026, filed 21 Sep 2026.